|
|
The U.S. Food and Drug Administration (FDA) is aware that Fresenius Kabi has sent letters to affected customers regarding two different issues that could delay or interrupt treatment and recommended all infusion pumps be corrected prior to continued use.
These recalls involve correcting devices and does not involve removing them from where they are used or sold. The FDA has identified these recalls as the most serious type. These devices may cause serious injury or death if you continue to use them without correction.
Questions?
Customers in the U.S. with adverse reactions, quality problems, or questions about either recall should contact Fresenius Kabi Support at Ivenix_support@fresenius-kabi.com or (855) 354-6387.
|
|
|
|